CytRx is a biopharmaceutical research and development company focusing on oncology. Co. focuses on the discovery, research and clinical development of anti-cancer drug candidates that utilize LADR™ (Linker Activated Drug Release) technology platform to develop the accumulation and release of cytotoxic anti-cancer agents at the tumor. Co. has worked to develop and focused on the research and clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. Aldoxorubicin is a conjugate of the commonly prescribed chemotherapeutic agent doxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of tumors. We show 8 historical shares outstanding datapoints in our CYTR shares outstanding history coverage, used to compute CYTR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CYTR market cap history over the course of time is important for investors
interested in comparing CYTR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CYTR versus a peer is one thing; comparing
CYTR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CYTR can fluctuate over the course of history.
With this page we aim to empower investors researching CYTR by allowing them to research the CYTR market cap history. |
Free CYTR Email Alerts:
Video: The Importance of Market Cap
